| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ZyVersa Therapeutics, Inc. | Chief Financial Officer | Stock Options | 60.1K | Jul 11, 2025 | Direct | ||
| ZyVersa Therapeutics, Inc. | Chief Financial Officer | Stock Options | 715 | May 24, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. | Jul 11, 2025 | 1 | $0 | 4 | Jul 15, 2025 | Chief Financial Officer |
| ZVSA | ZyVersa Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | Jul 18, 2024 | Chief Financial Officer |
| ZVSA | ZyVersa Therapeutics, Inc. | Dec 16, 2022 | 1 | $8.64K | 4 | Dec 20, 2022 | Chief Financial Officer |
| ZVSA | ZyVersa Therapeutics, Inc. | Dec 12, 2022 | 8 | $0 | 4 | Dec 14, 2022 | Chief Financial Officer |
| ZVSA | ZyVersa Therapeutics, Inc. | Dec 12, 2022 | 0 | $0 | 3 | Dec 13, 2022 | Chief Financial Officer |